Briefing Industry news Industry briefing Covid-19 briefing NEWS FDA approves Gilead’s Veklury for Covid-19 in paediatric patients BRIEFING Glyscend concludes Phase I trial of oral type 2 diabetes therapy In the trial, GLY-200 was found to be well-tolerated across all tested dose levels without any safety signals detected. covid-19 Covid-19 vaccines and strong capital markets still drive Pharma growth According to an ongoing GlobalData poll, the biggest impact of the Covid-19 pandemic has been in supply chain. Industry news Industry briefing Covid-19 briefing 06/01/2022 13:47:59
covid-19
Covid-19 vaccines and strong capital markets still drive Pharma growth
According to an ongoing GlobalData poll, the biggest impact of the Covid-19 pandemic has been in supply chain.